Press release
September 11, 2026
Outlook Therapeutics Fireside Chat from H.C. Wainwright Conference Now Available On-Demand
Outlook Therapeutics, Inc. (OTLK)
Fireside chat featuring Bob Jahr, Chief Executive Officer, and H.C. Wainwright Managing Director & Senior Biotechnology Equity Research Analyst Access the video webcast here ISELIN, N.J., Sept. 11, 2026 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company